“…Not surprisingly, studies have shown that many pharmaceuticals have been detected in rivers (ng/L−μg/L), , aquatic vertebrates (e.g., fish), and invertebrates (e.g., gammarids) (ng/g−μg/g). − Diclofenac as a widely used NSAID in both humans and livestock, has been widely found in various environmental media, including in the ng/L to μg/L range in surface waters and ng/g to μg/g range in aquatic organisms. ,, Even though the detected concentrations are low, pharmaceuticals may pose a risk to the nontarget organisms in the aquatic ecosystems because they are designed to be biologically active at low doses for targeted organisms (e.g., humans) and often have a specific mechanism of action (MoA). For example, the pharmacological MoA of diclofenac in humans is the reduction of prostaglandin synthesis by inhibiting cyclooxygenase-1 (COX-1) and COX-2. , Interestingly, a few studies have shown that diclofenac also affects the prostaglandin metabolome in several nontarget organisms such as rainbow trout ( Oncorhynchus mykiss ), zebrafish ( Danio rerio ), and marine mussels ( Mytilus galloprovincialis ) by using metabolomics. , Also, studies have shown that exposure of diclofenac induces adverse effects in different aquatic vertebrates and invertebrates, ,,− as exemplified by the toxic effects in different organs (e.g., cytological alterations in the liver, kidney, and gills) of rainbow trout exposed to environmentally relevant concentrations (1–5 μg/L) …”